VectorY Therapeutics
Latest round
- Series A
Last raised
- Nov 2023
Total raised
- $175M
Investors
- 7
About VectorY Therapeutics
Founded in 2020 and based in Amsterdam, Netherlands, VectorY operates as a biotechnology company that focuses on therapeutic solutions. VectorY develops gene therapy for muscular and neurodegenerative disorders. The firm develops vectorized antibodies for CNS and somatic disorders.
Who invested in VectorY Therapeutics
7 investors across 2 rounds
See all investors in VectorY Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about VectorY Therapeutics
Who invested in VectorY Therapeutics?
VectorY Therapeutics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has VectorY Therapeutics raised?
VectorY Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did VectorY Therapeutics last raise money?
VectorY Therapeutics's most recent round on record is a Series A, in Nov 2023.
What does VectorY Therapeutics do?
Founded in 2020 and based in Amsterdam, Netherlands, VectorY operates as a biotechnology company that focuses on therapeutic solutions.
Where is VectorY Therapeutics headquartered?
VectorY Therapeutics is headquartered in Amsterdam, Netherlands.
Which VCs invest in companies like VectorY Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at VectorY Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like VectorY Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.